Reckitt Benckiser Group plc (LON:RKT)

Market Cap	33.48B
Revenue (ttm)	14.17B
Net Income (ttm)	1.43B
Shares Out	681.79M
EPS (ttm)	2.03
PE Ratio	24.09
Forward PE	14.15
Dividend	2.02 (4.11%)
Ex-Dividend Date	Apr 10, 2025

Volume	1,148,117
Average Volume	1,427,657
Open	4,880.00
Previous Close	4,912.00
Day's Range	4,857.00 - 4,928.00
52-Week Range	4,034.00 - 5,418.00
Beta	0.17
RSI	43.05
Earnings Date	Jul 24, 2025

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol bran...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1819
• Employees: 37,900
• Stock Exchange: London Stock Exchange
• Ticker Symbol: RKT

Financial Performance

In 2024, Reckitt Benckiser Group's revenue was 14.17 billion, a decrease of -3.00% compared to the previous year's 14.61 billion. Earnings were 1.43 billion, a decrease of -13.21%.